Independent provider comparison
Updated September 21, 2026
Found vs Hers: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
The decision
Which should you choose, Found or Hers?
Short answer: Found scores higher on our published rubric, 7.3/10 against 5.3/10. Published pricing is not a like-for-like monthly comparison: Found is published $148/mo; total not verified; Hers is $188 first month, then $298/mo.
Consider Found if
Patients with commercial insurance who want their GLP-1 coverage checked before they pay, and Medicare Part D members aged 65 to 75 going through the GLP-1 Bridge.
Consider Hers if
Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Found
#16 of 37Best for patients with commercial insurance who want their glp-1 coverage checked before they pay, and medicare part d members aged 65 to 75 going through the glp-1 bridge.
Visit Found
Hers
#26 of 37Best for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Visit HersSide by side
Found vs Hers at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Found | Hers |
|---|---|---|
Why each oneFoundOne of the only GLP-1 platforms that actively coordinates with insurance companies, offers a GLP-1 coverage check, and prescribes from 10+ medications. HersA major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | ||
| Our Score | 7.3/10 | 5.3/10 |
| Headline Price | published $148/mo; total not verified | $188 first month, then $298/mo |
| Medication Type | Both | Both |
| Insurance Accepted | Yes | No |
Best ForFoundPatients with commercial insurance who want their GLP-1 coverage checked before they pay, and Medicare Part D members aged 65 to 75 going through the GLP-1 Bridge HersWomen who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | ||
Watch out forFoundThe advertised prices need a 12 month plan paid up front. Found's pricing page lists $169/mo cash or $99/mo insured on that plan, and $289/mo cash or $199/mo insured if you pay month to month HersPending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). | ||
| Ranking | #16 | #26 |
| Get started | Visit Found | Visit Hers |
Trade-offs
Strengths and cautions compared
Found
Pros
- +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
- +With insurance the plan starts at $99/mo on a 12 month term, below its own $169/mo cash figure, plus a copay Found puts at around $30 for most members
1 more documented strengths
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −The advertised prices need a 12 month plan paid up front. Found's pricing page lists $169/mo cash or $99/mo insured on that plan, and $289/mo cash or $199/mo insured if you pay month to month
- −The insurance route adds steps compared with flat cash-pay platforms, and the copay Found quotes at around $30 for most members is charged on top of the plan price, not instead of it
- −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
1 more documented strengths
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
2 more documented cautions
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Found edges out Hers with a score of 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Found is published $148/mo; total not verified; Hers is $188 first month, then $298/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Coverage decisionCheck your GLP-1 insurance pathLook up plan-specific coverage questions before treating a cash price or an insurance route as your final out-of-pocket cost.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
Reviews and pricing sources
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Found legit and is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Found · 7.3/10